USPTO extends COVID-19 Prioritized Examination Pilot Program

[[VIEW_THIS]]

Patent Alert

USPTO extends COVID-19 Prioritized Examination Pilot Program until May 11, 2023

The United States Patent and Trademark Office (USPTO) announced a sixth extension of the COVID-19 Prioritized Examination Pilot Program. The program supports the acceleration of innovations in the fight against COVID-19. Requests to participate that are compliant with the program’s requirements, and are filed on or before May 11, will be accepted.

As of January 9, 364 patents were issued from applications granted prioritized status under this program. The average total pendency for those applications was 356 days. The shortest pendency from filing date to issue date for those applications was 75 days.

The full text of the notice is available on the Patent Related Notices webpage. Please see the USPTO’s COVID-19 Prioritized Examination Pilot Program webpage for more information about the program.

​​​

Stay connected with the USPTO by subscribing to regular email updates.

Visit our subscription center at www.uspto.gov/subscribe to update or change your email preferences.

This email was sent from an unmonitored mailbox. To contact us, please visit our website www.uspto.gov/about/contacts. To ensure that you continue to receive our news and notices, please modify your email filters to allow mail from subscriptioncenter@subscriptions.uspto.gov.